Anemia, RefractoryRefractory Period, ElectrophysiologicalAnemia, Refractory, with Excess of BlastsTreatment OutcomeSalvage TherapyRecurrenceDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmAntineoplastic AgentsRemission InductionAntibodies, Monoclonal, Murine-DerivedThalidomideInfusions, IntravenousAnticonvulsantsCytarabineDrug ResistanceTreatment FailureRefractory Period, PsychologicalBoronic AcidsEpilepsyPyrazinesEtoposideAntibodies, MonoclonalMaximum Tolerated DoseDose-Response Relationship, DrugDrug EvaluationAnemia, SideroblasticMultiple MyelomaLymphoma, Non-HodgkinFollow-Up StudiesTransplantation, AutologousHodgkin DiseasePain, IntractableTime FactorsArabinonucleosidesEpilepsies, PartialRetrospective StudiesVidarabineNeoplasm Recurrence, LocalHeart Conduction SystemDisease-Free SurvivalPiracetamDrug Therapy, CombinationImmunosuppressive AgentsCyclophosphamideMyelodysplastic SyndromesAtrioventricular NodeAnti-Arrhythmia AgentsCombined Modality TherapyHematopoietic Stem Cell TransplantationCardiac Pacing, ArtificialThrombocytopeniaNeoplasmsAscitesSurvival AnalysisRetreatmentVagus Nerve StimulationAtrial FibrillationStatus EpilepticusNitrogen Mustard CompoundsHeart AtriaMitoxantroneSurvival RateLeukemia, Myeloid, AcuteDexamethasoneIfosfamideAdministration, OralImmunologic FactorsElectrocardiographyMineral FibersProspective StudiesMelphalanNauseaPurpura, Thrombocytopenic, IdiopathicNeutropeniaLeukemia, Lymphocytic, Chronic, B-CellPeritoneovenous ShuntElectric Stimulation TherapyAntibodies, Monoclonal, HumanizedTopotecanEpilepsy, Temporal LobeChronic DiseaseAntigens, CD20Epilepsy, Complex PartialTachycardiaAntineoplastic Agents, PhytogenicPrognosisLeukemiaCarmustineLymphoma, Mantle-CellCatheter AblationDogsCounterpulsationEpilepsy, GeneralizedCamptothecinAction PotentialsIdarubicinPouchitisPsychosurgery